Pei Shi Ong

Celastrol in cancer therapy: Recent developments, challenges and prospects

Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang et al. · Cancer Letters · 2021 · 118 citations

Medicine, Oncology, Pharmacology +9

Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling

Lingzhi Wang, Nicholas Syn, Vinod Vijay Subhash et al. · Cancer Letters · 2018 · 77 citations

Medicine, Oncology, Pharmacology +12

A miniaturized flow-through cell to evaluate skin permeation of endoxifen

Choon Siong Mah, Jaspreet Singh Kochhar, Pei Shi Ong et al. · International Journal of Pharmaceutics · 2012 · 22 citations

Pharmacy, Biomedical Engineering, Pharmacology +11

Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study

Joel Jun Kai Koh, Rui Xiang Cheng, Yicheng Yap et al. · Patient Preference and Adherence · 2018 · 19 citations · Full text

Medicine, Cardiology, Pharmacotherapy +13

Quantification of trans-2,6-difluoro-4′-N,N-dimethylaminostilbene in rat plasma: Application to a pharmacokinetic study

Hai‐Shu Lin, Vitaliy M. Sviripa, David S. Watt et al. · Journal of Pharmaceutical and Biomedical Analysis · 2012 · 11 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +4